Alpha Teknova (NASDAQ:TKNO) Hits New 1-Year High – Here’s What Happened

Shares of Alpha Teknova, Inc. (NASDAQ:TKNO) reached a new 52-week high during trading on Tuesday . The stock traded as high as $9.72 and last traded at $9.45, with a volume of 208104 shares changing hands. The stock had previously closed at $7.68.

Alpha Teknova Stock Up 12.0 %

The business’s fifty day simple moving average is $7.28 and its two-hundred day simple moving average is $4.84. The company has a debt-to-equity ratio of 0.12, a current ratio of 4.73 and a quick ratio of 3.94. The company has a market cap of $458.45 million, a PE ratio of -11.62 and a beta of 0.37.

Alpha Teknova (NASDAQ:TKNO) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.04). The business had revenue of $9.58 million for the quarter, compared to analysts’ expectations of $9.30 million. Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. During the same quarter in the prior year, the company posted ($0.34) EPS. On average, analysts predict that Alpha Teknova, Inc. will post -0.58 earnings per share for the current year.

Institutional Trading of Alpha Teknova

Several institutional investors have recently modified their holdings of the stock. State Street Corp raised its position in shares of Alpha Teknova by 249.3% during the 3rd quarter. State Street Corp now owns 76,645 shares of the company’s stock worth $371,000 after purchasing an additional 54,700 shares during the last quarter. Geode Capital Management LLC increased its stake in Alpha Teknova by 24.4% during the 3rd quarter. Geode Capital Management LLC now owns 188,173 shares of the company’s stock worth $911,000 after buying an additional 36,914 shares in the last quarter. Point72 Asset Management L.P. acquired a new position in shares of Alpha Teknova during the third quarter valued at approximately $1,483,000. Finally, Roubaix Capital LLC purchased a new position in shares of Alpha Teknova in the third quarter valued at approximately $2,015,000. Institutional investors and hedge funds own 13.81% of the company’s stock.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.